ES2555864T3 - Ensayo para la medición de anticuerpos de unión a un anticuerpo monoclonal terapéutico - Google Patents

Ensayo para la medición de anticuerpos de unión a un anticuerpo monoclonal terapéutico Download PDF

Info

Publication number
ES2555864T3
ES2555864T3 ES11746230.9T ES11746230T ES2555864T3 ES 2555864 T3 ES2555864 T3 ES 2555864T3 ES 11746230 T ES11746230 T ES 11746230T ES 2555864 T3 ES2555864 T3 ES 2555864T3
Authority
ES
Spain
Prior art keywords
acmt
antibody
monoclonal antibody
sample
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11746230.9T
Other languages
English (en)
Spanish (es)
Inventor
Veit Peter Grunert
Ursula Klause
Pavel Kubalec
Matthias Rothfuss
Barbara Upmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2555864T3 publication Critical patent/ES2555864T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES11746230.9T 2010-08-19 2011-08-17 Ensayo para la medición de anticuerpos de unión a un anticuerpo monoclonal terapéutico Active ES2555864T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10173408 2010-08-19
EP10173408 2010-08-19
PCT/EP2011/064178 WO2012022774A1 (en) 2010-08-19 2011-08-17 An assay for measurement of antibodies binding to a therapeutic monoclonal antibody

Publications (1)

Publication Number Publication Date
ES2555864T3 true ES2555864T3 (es) 2016-01-11

Family

ID=42727619

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11746230.9T Active ES2555864T3 (es) 2010-08-19 2011-08-17 Ensayo para la medición de anticuerpos de unión a un anticuerpo monoclonal terapéutico

Country Status (7)

Country Link
US (1) US9081016B2 (enExample)
EP (1) EP2606362B1 (enExample)
JP (1) JP5805190B2 (enExample)
CN (1) CN103109190B (enExample)
CA (1) CA2802278A1 (enExample)
ES (1) ES2555864T3 (enExample)
WO (1) WO2012022774A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104614535B (zh) * 2015-02-10 2017-11-28 深圳市新产业生物医学工程股份有限公司 甲状腺微粒体抗体检测试剂盒及其制备方法和应用
EP3482199A1 (en) * 2016-07-08 2019-05-15 Atonomics A/S A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples
CN106093413A (zh) * 2016-07-18 2016-11-09 本·沙朗 一种抗英夫利西抗体elisa检测试剂盒和检测方法
US11698367B2 (en) * 2017-09-15 2023-07-11 Beckman Coulter, Inc. Flow based assays for therapeutics
WO2019191280A1 (en) * 2018-03-27 2019-10-03 Laboratory Corporation Of America Holdings Sandwich elisa for identifying subjects who may benefit from treatment with therapeutic agents
JP7570421B2 (ja) * 2020-01-02 2024-10-21 エフ． ホフマン－ラ ロシュ アーゲー Ａｄａ応答特定アッセイ
CN115552244A (zh) * 2020-05-08 2022-12-30 豪夫迈·罗氏有限公司 用于高药物耐受性测试的高离子强度解离测定
CN117590002B (zh) * 2023-11-23 2024-10-22 上海领检科技有限公司 一种TNFα抗药抗体的检测方法及检测试剂盒

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508132A (en) 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4554088A (en) 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4628037A (en) 1983-05-12 1986-12-09 Advanced Magnetics, Inc. Binding assays employing magnetic particles
US4695393A (en) 1983-05-12 1987-09-22 Advanced Magnetics Inc. Magnetic particles for use in separations
US4698302A (en) 1983-05-12 1987-10-06 Advanced Magnetics, Inc. Enzymatic reactions using magnetic particles
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
EP0170302A1 (fr) 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
JPH0823558B2 (ja) 1984-11-27 1996-03-06 オ−ジエニクス リミテツド 検定装置
DE3689645D1 (de) 1985-10-16 1994-03-24 Fresenius Ag Selektives Adsorbens zur Bindung von Immunkomplexen.
EP0243471A4 (en) 1985-10-22 1989-07-11 Cooper Lipotech Inc SOLID PHASE LIPOSOME IMMUNOANALYSIS SYSTEM.
US6316607B1 (en) 1986-04-30 2001-11-13 Igen International, Inc. Electrochemiluminescent assays
US4965392A (en) 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5935779A (en) 1988-11-03 1999-08-10 Igen International Inc. Methods for improved particle electrochemiluminescence assay
GB8803000D0 (en) 1988-02-10 1988-03-09 Ekins Roger Philip Determination of ambient concentrations of several analytes
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
KR0143993B1 (ko) 1988-11-03 1998-07-15 리차아드 제이 매씨이 전기화학 발광성 분석
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
WO1990006515A1 (en) 1988-12-09 1990-06-14 Centocor, Inc. Anti-idiotopic immunometric assay
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
KR100272077B1 (ko) 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5364930A (en) 1990-10-16 1994-11-15 Northwestern University Synthetic C1q peptide fragments
WO1992009690A2 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
WO1993008472A1 (en) 1991-10-15 1993-04-29 Multilyte Limited Binding assay employing labelled reagent
AU3178993A (en) 1991-11-25 1993-06-28 Enzon, Inc. Multivalent antigen-binding proteins
US5466416A (en) 1993-05-14 1995-11-14 Ghaed; Ali Apparatus and methods for carrying out electrochemiluminescence test measurements
US6241963B1 (en) 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
DE19806989A1 (de) 1998-02-19 1999-08-26 Roche Diagnostics Gmbh Erzeugung räumlich scharf begrenzter Festphasen für Bindungsassays
IT1315254B1 (it) 1999-11-05 2003-02-03 Diesse Diagnostica Senese Spa Metodo per la determinazione qualitativa e quantitativa di anticorpiumani di classe igc.
DE60025526T2 (de) 1999-11-16 2006-08-24 Genentech, Inc., South San Francisco Elisa für vegf
US20050130246A1 (en) 2003-10-27 2005-06-16 Hossein Salimi-Moosavi Detecting human anti-therapeutic antibodies
DE102004052729A1 (de) 2004-10-30 2006-05-04 Roche Diagnostics Gmbh Immunkomplex-spezifsicher Antikörper zur Reduktion des Nullwerts beim Nachweis von Antigen-spezifisch gebundenen Antikörpern einer bestimmten Immunglobulinklasse in Array-Testformaten
DK2645106T4 (da) 2005-04-04 2024-12-02 Biogen Ma Inc Fremgangsmåder til evaluering af et immunrespons på et terapeutisk middel
MX2008012013A (es) 2006-03-23 2008-10-03 Novartis Ag Tratamiento con anticuerpo antigeno de celulas neoplasicas.
KR20090094814A (ko) 2006-10-10 2009-09-08 스퀴코어 암의 치료 및 진단을 위한 조성물 및 방법
WO2009003082A2 (en) * 2007-06-26 2008-12-31 Vanderbilt University Immunological compositions as cancer biomarkers and/or therapeutics

Also Published As

Publication number Publication date
EP2606362B1 (en) 2015-09-30
EP2606362A1 (en) 2013-06-26
CN103109190B (zh) 2015-07-22
CN103109190A (zh) 2013-05-15
US9081016B2 (en) 2015-07-14
HK1180767A1 (en) 2013-10-25
US20130157892A1 (en) 2013-06-20
CA2802278A1 (en) 2012-02-23
JP2013536419A (ja) 2013-09-19
JP5805190B2 (ja) 2015-11-04
WO2012022774A1 (en) 2012-02-23

Similar Documents

Publication Publication Date Title
ES2555864T3 (es) Ensayo para la medición de anticuerpos de unión a un anticuerpo monoclonal terapéutico
US20070166776A1 (en) Immunoassay and kit for an early and simultaneous detection of biochemical markers in a patient's sample
JP2021531448A (ja) 抗薬物抗体（ａｄａ）免疫アッセイにおける薬物標的干渉を軽減するための方法
JP5786020B2 (ja) 関節リウマチを診断する方法および試薬
RS55804B1 (sr) Testovi za adrenomedulin i metodi za određivanje zrelog adrenomedulina
WO2015106311A1 (en) Cell surface prostate cancer antigen for diagnosis
US20170146541A1 (en) Detection of high-risk intraductal papillary mucinous neoplasm and pancreatic adenocarcinoma
CN110687282A (zh) PD-1和/或p53自身抗体作为肿瘤疗效预测或预后评估的标志物
CA2662012A1 (en) Boris isoforms and methods of detecting and treating disease
EP2707720B1 (en) Diagnosis and prognosis of triple negative breast and ovarian cancer
ES2583684T3 (es) ARMET como marcador de la enfermedad pulmonar obstructiva crónica (EPOC)
ES2366123T3 (es) Método para la determinación de anticuerpos de una clase específica utilizando un anticuerpo inmunocomplejo específico.
US20120190563A1 (en) Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
US20120115745A1 (en) Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
MX2012012986A (es) Metodos para predecir la sensibilidad al tratamiento con un inhibidor de cinasa de tirosina dirigido.
CN110687284B (zh) 检测血清中six2自身抗体的试剂的应用
WO2022118947A1 (ja) 抗体を測定する方法およびキット
HK1180767B (en) An assay for measurement of antibodies binding to a therapeutic monoclonal antibody
JP7222501B2 (ja) 末端シアル酸残基がα２，３結合でガラクトースに結合した糖鎖に特異的に結合するモノクローナル抗体、及び、末端シアル酸残基がα２，３結合でガラクトースに結合した糖鎖の測定方法
AU2002346529B2 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
Chourb Enhanced immuno-detection of breast cancer biomarkers: Shed extracellular domain of Her-2/neu and CA 15-3